Remove CBD Remove DEA Remove Extraction
article thumbnail

Doctor Sues DEA for Right to Give Psilocybin to Ailing Patients

Project CBD

Psilocybin, the psychedelic mushroom extract, has been fast-tracked by the FDA to treat depression, but doctors still can’t use it in their practice.

DEA 344
article thumbnail

DEA Promises Progress on Federal Cultivation Applications, But Provides No Timetable for Action

NORML

The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.

DEA 169
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves CBD-Containing Drug - Will the DEA Finally Step Up?

MJ Business Attorneys

Food and Drug Administration (FDA) approved Epidiolex, a drug containing Cannabidiol (CBD). Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. As the Controlled Substances Act (CSA) currently stands, CBD is still a Schedule I substance, which classifies CBD as having no medicinal uses.

DEA 113
article thumbnail

10 Tips for Buying Hemp-Derived CBD Products

Project CBD

With Congress seemingly poised to legalize the cultivation of industrial hemp for many uses, including the production of biomass for CBD oil extraction, many questions remain unanswered. How will the DEA reschedule CBD now that Epidiolex has been approved as a pharmaceutical CBD isolate?

Hemp 203
article thumbnail

Doctor Sues DEA for Right to Give Psilocybin to Dying Patients

Project CBD

Psilocybin, the psychedelic mushroom extract, has been fast-tracked by the FDA to treat depression, but doctors still can’t use it in their practice.

DEA 150
article thumbnail

DEA Attempts To Regulate CBD Processing

Greenspoon Marder Cannabis Law Group Blog

Drug Enforcement Administration (“DEA”) published an interim final rule surrounding hemp and hemp derivatives. Simply stated, when the hemp plant is processed and its cannabinoids are extracted into a crude oil, or similar derivative, concentrated amounts of ? By: Nabil Rodriguez. Last week on Thursday August 20, 2020, the U.S.

DEA 40
article thumbnail

The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?

Freedom Leaf

Though it doesn’t get users high like THC-dominant products, CBD is all the rage these days due to its medical benefits and gray-area legality. On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances.

DEA 51